{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:22:42Z","timestamp":1763389362142,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jasc.2020.10.003","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T19:34:04Z","timestamp":1602358444000},"page":"25-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["High-grade urothelial carcinoma with hypochromatic chromatin in urine cytology"],"prefix":"10.1016","volume":"10","author":[{"given":"Andrew A.","family":"Renshaw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin W.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2020.10.003_bib1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/cncy.21449","article-title":"The value of the \u201csuspicious for urothelial carcinoma\u201d cytology category: a correlative study of 4 years including 337 patients","volume":"122","author":"Ton Nu","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.10.003_bib2","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.7314\/APJCP.2014.15.5.2251","article-title":"Clinical value of dividing false positive urine cytology findings into three categories: atypical, indeterminate, and suspicious of malignancy","volume":"15","author":"Matsumoto","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jasc.2020.10.003_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2303.2010.00827.x","article-title":"The clinical significance of class III (suspicious) urine cytology","volume":"22","author":"Sternberg","year":"2011","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2020.10.003_bib4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jasc.2015.01.003","article-title":"Urine cytology: does the number of atypical urothelial cells matter? A qualitative and quantitiative study of 112 cases","volume":"4","author":"Brimo","year":"2015","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.10.003_bib5","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/dc.23159","article-title":"Does subdivision of the \u201catypical\u201d urine cytology increase predictive accuracy for urothelial carcinoma?","volume":"42","author":"Bostwick","year":"2014","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2020.10.003_bib6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1309\/AJCPPRZLG9KT9AXL","article-title":"Accuracy of urine cytology and the significance of an atypical category","volume":"132","author":"Brimo","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2020.10.003_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jasc.2014.11.002","article-title":"Subclassifying atypia in urine cytology: what are the helpful features?","volume":"4","author":"McCroskey","year":"2015","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.10.003_bib8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/cncr.21317","article-title":"Analysis of atypical urine cytology in a tertiary care center","volume":"105","author":"Deshpande","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jasc.2020.10.003_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/dc.23468","article-title":"The impact of subdividing the \u201catypical\u201d category for urinary cytology on patient management","volume":"44","author":"Glass","year":"2016","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2020.10.003_bib10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/cncy.21630","article-title":"Two-tiered subdivision of atypia on urine cytology can improve patient follow-up and optimize the utility of UroVysion","volume":"124","author":"Glass","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.10.003_bib11","doi-asserted-by":"crossref","first-page":"27 e21","DOI":"10.1016\/j.urolonc.2012.09.011","article-title":"Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer","volume":"32","author":"Yafi","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jasc.2020.10.003_bib12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1586\/14737159.3.4.507","article-title":"Vysis uroVysion for the detection of urothelial carcinoma","volume":"3","author":"Halling","year":"2003","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jasc.2020.10.003_bib13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/dc.23257","article-title":"The application of the Johns Hopkins Hospital Template on urine cytology","volume":"43","author":"Wu","year":"2015","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2020.10.003_bib14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/(SICI)1097-0142(19990625)87:3<118::AID-CNCR4>3.0.CO;2-N","article-title":"The accuracy of urinary cytology in daily practice","volume":"87","author":"Bastacky","year":"1999","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.10.003_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/cncy.21477","article-title":"Accuracy and risk of malignancy for diagnostic categories in urine cytology at a large tertiary institution","volume":"123","author":"Chau","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.10.003_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.urolonc.2014.06.008","article-title":"Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer","volume":"33","author":"Yafi","year":"2015","journal-title":"Urol Oncol"},{"year":"2016","series-title":"The Paris System for Reporting Urinary Cytology","author":"Rosenthal","key":"10.1016\/j.jasc.2020.10.003_bib17"},{"key":"10.1016\/j.jasc.2020.10.003_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000464270","article-title":"Utility of the Paris System in Reporting Urine Cytology","volume":"61","author":"Malviya","year":"2017","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2020.10.003_bib19","first-page":"427","article-title":"Improved risk stratification for patients with high-grade urothelial carcinoma following application of The Paris System for Reporting Urinary Cytology","volume":"125","author":"Cowan","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.jasc.2020.10.003_bib20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/ajcp\/aqw127","article-title":"Impact of implementing The Paris System for Reporting Urine Cytology in the performance of urine cytology: a correlative study of 124 cases","volume":"146","author":"Hassan","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2020.10.003_bib21","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/cncy.21764","article-title":"The positive predictive value of \u201csuspicious for high-grade urothelial carcinoma\u201d in urinary tract cytology specimens: a single-institution study of 665 cases","volume":"124","author":"Joudi","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.10.003_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000452092","article-title":"Applying The Paris System for Reporting Urine Cytology increases the rate of atypical urothelial cells in benign cases: a need for patient management recommendations","volume":"61","author":"Granados","year":"2017","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2020.10.003_bib23","doi-asserted-by":"crossref","first-page":"s30","DOI":"10.1016\/j.jasc.2014.09.063","article-title":"Cytologic features of atypical urine specimens predictive of high grade urothelial carcinoma","volume":"3","author":"Feasel","year":"2014","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.10.003_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/cyt.12050","article-title":"Diagnostic terminology for urinary cytology reports including the new subcategories \u2018atypical urothelial cells of undetermined significance\u2019 (AUC-US) and \u2018cannot exclude high grade\u2019 (AUC-H)","volume":"25","author":"Piaton","year":"2014","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2020.10.003_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1742-6413-3-28","article-title":"Malignant atypical cell in urine cytology: a diagnostic dilemma","volume":"3","author":"Bhatia","year":"2006","journal-title":"Cytojournal"},{"key":"10.1016\/j.jasc.2020.10.003_bib26","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2020.10.003_bib27","series-title":"Cytology. Diagnostic Principles and Clinical Correlates","first-page":"105","article-title":"Urine and bladder washings","author":"Renshaw","year":"1996"},{"key":"10.1016\/j.jasc.2020.10.003_bib28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jasc.2018.07.006","article-title":"Utility of The Paris System for Reporting Urinary Cytology in upper urinary tract specimens","volume":"7","author":"Xing","year":"2018","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.10.003_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000481908","article-title":"High grade urothelial carcinoma in urine cytology resembling umbrella cells","volume":"62","author":"Renshaw","year":"2018","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2020.10.003_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/cncy.21947","article-title":"High grade urothelial carcinoma in urine cytology with jet black chromatin","volume":"126","author":"Renshaw","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.10.003_bib31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/apm.12877","article-title":"Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma","volume":"126","author":"Pierconti","year":"2018","journal-title":"APMIS"},{"key":"10.1016\/j.jasc.2020.10.003_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/cncy.21709","article-title":"Comparison between cytospin and liquid-based cytology in urine specimens classified according to The Paris System for Reporting Urinary Cytology","volume":"124","author":"Straccia","year":"2016","journal-title":"Cancer Cytopathol"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294520303240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294520303240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:46:57Z","timestamp":1761979617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294520303240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2213294520303240"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2020.10.003","relation":{},"ISSN":["2213-2945"],"issn-type":[{"type":"print","value":"2213-2945"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-grade urothelial carcinoma with hypochromatic chromatin in urine cytology","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2020.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}